NVSNovartis

Median target
$170
calls from the last 12 months
Implied return
+20.6%
median target vs. price
Coverage
10 analysts · 11 calls
updated in the last 12 months
Consensus
6/4/0+6 net
Buy / Hold / Sell

Which analysts are behind NVS's consensus?

See every current rating, price target and the analysts' track records for Novartis — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 10 analysts with calls on NVS updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

NVS elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: #38 in Losing attention (0.8× vs usual)

DateSourceWhoActionDetailAmount
2026-01-30ExecutiveMody, ArjunDeputy CommissionerSaleNovartis AG Common Stock (NVS)$1,001 - $15,000
2025-10-31CongressLisa McClainMI-MI09Salesince trade +16.8%, vs market -4.5%$1K–$15K
2025-10-30CongressLisa McClainMI-MI09Purchasesince trade +18.0%, vs market +5.3%$1K–$15K
2025-10-30CongressLisa McClainMI-MI09Salesince trade +18.0%, vs market -5.3%$1K–$15K
2025-09-25CongressLisa McClainMI-MI09Salesince trade +18.3%, vs market -1.9%$1K–$15K
2025-09-11CongressLisa McClainMI-MI09Purchasesince trade +13.3%, vs market -3.5%$1K–$15K
2025-07-22CongressLisa McClainMI-MI09Salesince trade +23.8%, vs market -1.7%$1K–$15K
2025-06-17CongressLisa McClainMI-MI09Purchasesince trade +24.3%, vs market -4.7%$1K–$15K
2025-06-11CongressLisa McClainMI-MI09Purchasesince trade +22.5%, vs market -5.6%$1K–$15K
2025-06-10CongressLisa McClainMI-MI09Salesince trade +22.0%, vs market +5.8%$1K–$15K

More: congressional trades on NVS · insider activity · executive branch · trending